Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

Akụkọ

Nsonaazụ dị mkpa nke ọgwụgwọ CAR-T nke CD7 maka T-ALL na T-LBL

Nsonaazụ dị mkpa nke ọgwụgwọ CAR-T nke CD7 maka T-ALL na T-LBL

2024-06-18

Nnyocha e mere n'oge na-adịbeghị anya na-egosi nsonaazụ dị mma nke ọgwụgwọ mkpụrụ ndụ T nke CD7-targeted chimeric antigen receptor (CAR) na-agwọ ndị ọrịa nwere ọrịa leukemia T-cell acute lymphoblastic leukemia (T-ALL) na T-cell lymphoblastic lymphoma (T-LBL) nke na-alaghachi azụ ma ọ bụ na-adịghị ike.

lee nkọwa zuru ezu
Mkpuchi nke Nzukọ na Ngosipụta Kwa Afọ nke 2024 ASH

Mkpuchi nke Nzukọ na Ngosipụta Kwa Afọ nke 2024 ASH

2024-06-13

A ga-enwe Nzukọ Kwa Afọ nke 66 nke American Society of Hematology (ASH) site na Disemba 7 ruo 10, 2024, na San Diego Convention Center, na-egosi nchọpụta na ọganihu dị ukwuu na hematology.

lee nkọwa zuru ezu
Ịkpọsa Nzukọ Ọgwụ Lu Daopei nke Afọ 2024 n'ọnwa Ọgọst

Ịkpọsa Nzukọ Ọgwụ Lu Daopei nke Afọ 2024 n'ọnwa Ọgọst

2024-06-11

A ga-eme ogbako Lu Daopei Hematology nke afọ nke iri na abụọ n'ụbọchị iri abụọ na atọ ruo iri abụọ na anọ nke ọnwa Ọgọst, afọ 2024, na Beijing International Convention Center. Soro anyị maka mkparịta ụka bara uru na ọganihu kachasị ọhụrụ na hematology.

lee nkọwa zuru ezu
Olileanya Ọhụrụ n'Ọgwụgwọ Ọrịa Kansa: Ọgwụgwọ TILs Na-apụta dị ka Ebe Na-esote

Olileanya Ọhụrụ n'Ọgwụgwọ Ọrịa Kansa: Ọgwụgwọ TILs Na-apụta dị ka Ebe Na-esote

2024-06-05

N'agbanyeghị ihe ịma aka ndị na-aga n'ihu n'ịzụlite na ire ahịa n'ụlọ ọrụ mmepụta ihe, a na-edozi oke ọgwụgwọ CAR-T site na ụzọ ọhụrụ dị mma: ọgwụgwọ Lymphocytes nke na-abanye n'ime ahụ (TIL). Ihe ọhụrụ a na-egosi oge ọhụrụ n'ọgụ megide etuto ahụ siri ike.

lee nkọwa zuru ezu

Ọgwụgwọ Cellular Ọ̀ Bụ Ọdịnihu nke Ọrịa Mgbochi Onwe?

2024-04-30

Ọgwụgwọ ọhụrụ maka ọrịa kansa nwekwara ike inye aka gwọọ ma tọgharịa sistemu ahụ ji alụso ọrịa ọgụ iji nye mgbaghara ogologo oge ma ọ bụ ikekwe gwọọ ụfọdụ ọrịa autoimmune.

lee nkọwa zuru ezu
Mmepe ASH nke 2023 | Dr. Peihua Lu na-egosi CAR-T maka Nnyocha AML Relapsed/Refractory

Mmepe ASH nke 2023 | Dr. Peihua Lu na-egosi CAR-T maka Nnyocha AML Relapsed/Refractory

2024-04-09
Ọmụmụ ihe gbasara CD7 CAR-T maka R/R AML nke ndị otu Daopei Lu mere na ASH. E mere nzukọ kwa afọ nke 65 nke American Society of Hematology (ASH) n'ịntanetị (San Diego, USA) na n'ịntanetị na Disemba 9-12, 2023. Ndị ọkà mmụta anyị gosipụtara nke ọma nke ngalaba a...
lee nkọwa zuru ezu
ASH 2023|"Olu Lu Daopei" na-abụ abụ n

ASH 2023|"Olu Lu Daopei" na-abụ abụ n'elu ikpo okwu mba ụwa

2024-04-09
Òtù Ndị Na-ahụ Maka Ọrịa Hematology nke Amerịka (ASH) bụ nzukọ agụmakwụkwọ kachasị elu n'ọhịa nke ọrịa hematology n'ụwa niile. Eziokwu ahụ bụ na a họpụtara ụlọ ọgwụ Lu Daopei dị ka onye ikpeazụ maka ASH ruo ọtụtụ afọ n'usoro na-egosi nke ọma ihe ọ rụzuru n'agụmakwụkwọ ya na...
lee nkọwa zuru ezu
ASH Voice of China| Prọfesọ Xian Zhang: Ọrụ na Nchekwa Dị Elu nke Ọgwụgwọ Anti-BCMA CAR-T nke Nanobody na-agwọ n'ịgwọ ndị ọrịa nwere ọtụtụ Myeloma Relapsed ma ọ bụ Refractory

ASH Voice of China| Prọfesọ Xian Zhang: Ọrụ na Nchekwa Dị Elu nke Ọgwụgwọ Anti-BCMA CAR-T nke Nanobody na-agwọ n'ịgwọ ndị ọrịa nwere ọtụtụ Myeloma Relapsed ma ọ bụ Refractory

2024-04-09
E mere Nzukọ Kwa Afọ nke 65 nke American Society of Hematology (ASH) site na 9 ruo 12 Disemba 2023, na San Diego, USA. Dịka mmemme agụmakwụkwọ kachasị elu na nke zuru oke n'ụwa, ọ na-adọta ọtụtụ puku ndị ọkachamara na ndị ọkà mmụta si n'akụkụ niile...
lee nkọwa zuru ezu